---
trial_id: 258
discovery_date: 2022-03-29 21:28:27.995671
date: 2022-03-29 21:28:27.995671
title: "A Multi-Site, Open-Label Extension Trial of Oral RPC1063 in Relapsing Multiple Sclerosis"
summary: |
  <p>EudraCT Number: 2015-002500-91<br />Sponsor Protocol Number: RPC01-3001<br />Sponsor Name: Celgene International II Sàrl (CIS II)<br />Start Date: 2015-10-12<br />Medical condition: Relapsing Multiple Sclerosis<br />Disease: <br />Version: 20.0<br />SOC Term: 10029205 - Nervous system disorders<br />Classification Code: 10048393<br />Term: Multiple sclerosis relapse<br />Level: PT<br /><br />Population Age: Adults<br />Gender: Male, Female<br />Trial Protocol: <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-002500-91/HU">HU</a> (Ongoing), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-002500-91/BE">BE</a> (Ongoing), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-002500-91/GB">GB</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-002500-91/ES">ES</a> (Ongoing), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-002500-91/BG">BG</a> (Ongoing), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-002500-91/SK">SK</a> (Ongoing), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-002500-91/GR">GR</a> (Ongoing), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-002500-91/PL">PL</a> (Ongoing), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-002500-91/LV">LV</a> (Ongoing), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-002500-91/EE">EE</a> (Ongoing), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-002500-91/LT">LT</a> (Ongoing), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-002500-91/PT">PT</a> (Ongoing), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-002500-91/SE">SE</a> (Ongoing), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-002500-91/HR">HR</a> (Ongoing), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-002500-91/IT">IT</a> (Ongoing)</p>
link: 'https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-002500-91'
published_date: NaT
trial_source: Clinical Trials Register Europe
relevant: 
options:
  unlisted: false
---
<p>EudraCT Number: 2015-002500-91<br />Sponsor Protocol Number: RPC01-3001<br />Sponsor Name: Celgene International II Sàrl (CIS II)<br />Start Date: 2015-10-12<br />Medical condition: Relapsing Multiple Sclerosis<br />Disease: <br />Version: 20.0<br />SOC Term: 10029205 - Nervous system disorders<br />Classification Code: 10048393<br />Term: Multiple sclerosis relapse<br />Level: PT<br /><br />Population Age: Adults<br />Gender: Male, Female<br />Trial Protocol: <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-002500-91/HU">HU</a> (Ongoing), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-002500-91/BE">BE</a> (Ongoing), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-002500-91/GB">GB</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-002500-91/ES">ES</a> (Ongoing), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-002500-91/BG">BG</a> (Ongoing), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-002500-91/SK">SK</a> (Ongoing), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-002500-91/GR">GR</a> (Ongoing), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-002500-91/PL">PL</a> (Ongoing), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-002500-91/LV">LV</a> (Ongoing), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-002500-91/EE">EE</a> (Ongoing), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-002500-91/LT">LT</a> (Ongoing), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-002500-91/PT">PT</a> (Ongoing), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-002500-91/SE">SE</a> (Ongoing), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-002500-91/HR">HR</a> (Ongoing), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-002500-91/IT">IT</a> (Ongoing)</p>